Covid-19 Vaccine Mc Pharma 6.5 U Solution for intramuscular injection
PDF Leaflet Revision Date: 02 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of COVID-19 disease in adults and children over 18.
Dosage (summary)
0.5 ml intramuscular injection, two doses at 2-4 week intervals.
Special Populations
- Elderly
- Immunocompromised
Pregnancy & Breastfeeding
Use with caution in pregnant and lactating mothers; consult a physician.
Key Drug Interactions
- No clinical trial data on combination with other vaccines
- Inform physician of all medications
Contraindications
- Allergy to any component
- Serious chronic disease
- Acute fever or illness
Common side effects
- Pain at injection site
- Transient fever
- Fatigue
- Headache
- Diarrhea
Counselling Points
- Monitor for 30 mins post-vaccination
- Do not use after expiration date
- Store between 2u00b0C-8u00b0C
Serious warnings
- Intravascular injection prohibited
- Emergency treatment for severe allergic reactions should be available
- Caution in blood disorders and immune deficiencies
Important Disclaimer
The Covid-19 Vaccine Mc Pharma 6.5 U Solution for intramuscular injection professional information leaflet below is the property of Mc Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
